CLASS II Device recall · Reported 21 Jan 2015 · FDA Enforcement Report

Advia Chemistry XPT interfaced to the CentraLink Data recalled

Siemens Healthcare Diagnostics is recalling Advia Chemistry XPT interfaced to the CentraLink Data Management System V14x in specific, distributed in Washington. The recall was initiated on 16 Dec 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCentraLink" Data Management System V14x Catalog Numbers: 10817209, 10818262
Quantity recalled7

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0987-2015
FDA event ID
70078
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class II
Status
Terminated
Recall initiated
16 Dec 2014
FDA classified
15 Jan 2015
Reported
21 Jan 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

16 Dec 2014Recall initiated by company
15 Jan 2015Classified by FDA+30 days
21 Jan 2015Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Enabling sending of preliminary/initial results on the ADVIA Chemistry XPT creates a risk that a critical result could be overwritten by the same result rather than showing the repeated result on CentraLink. A result could be erroneous and critical and appear to be verified upon repeat.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

ADVIA Chemistry XPT interfaced to the CentraLink Data Management System V14x in specific configurations: The CentraLink system software is a network solution provider and multi-system data manager for the instruments and lab automation systems (LAS) within the lab. The CentraLink software consolidates data from all connected instruments so that an operator can review and edit patient and quality control results from a single location.

Where it was distributed

Distributed in the state of WA.

Washington

Questions about this recall

Why was it recalled?

Enabling sending of preliminary/initial results on the ADVIA Chemistry XPT creates a risk that a critical result could be overwritten by the same result rather than showing the repeated result on CentraLink. A result could be erroneous and critical and appear to be verified upon repeat.

Which lots are affected?

CentraLink" Data Management System V14x Catalog Numbers: 10817209, 10818262

Where was it sold?

Distributed in the state of WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Medical Software recalls

All 903